BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gidding HF, McCallum L, Fathima P, Moore HC, Snelling TL, Blyth CC, Jayasinghe S, Giele C, de Klerk N, Andrews RM, McIntyre PB; ACIR linkage Investigator Team. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia. Vaccine 2018;36:2650-6. [PMID: 29627233 DOI: 10.1016/j.vaccine.2018.03.058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Chan J, Gidding HF, Blyth CC, Fathima P, Jayasinghe S, McIntyre PB, Moore HC, Mulholland K, Nguyen CD, Andrews R, Russell FM. Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study. PLoS Med 2021;18:e1003733. [PMID: 34343186 DOI: 10.1371/journal.pmed.1003733] [Reference Citation Analysis]
2 Toh ZQ, Quang C, Tooma JA, Garland SM, Mulholland K, Licciardi PV. Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific. Vaccines (Basel) 2021;9:921. [PMID: 34452046 DOI: 10.3390/vaccines9080921] [Reference Citation Analysis]
3 Rinta-Kokko H, Nurhonen M, Auranen K. Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach. Hum Vaccin Immunother 2021;17:1834-43. [PMID: 33327857 DOI: 10.1080/21645515.2020.1836918] [Reference Citation Analysis]
4 Gidding HF, Sheridan S, Fathima P, Moore HC, Liu B, McIntyre PB, Palmu AA; ACIR Linkage Investigator Team. Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia. Pediatr Infect Dis J 2019;38:860-5. [PMID: 30985507 DOI: 10.1097/INF.0000000000002314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Madhi SA, Mutsaerts EA, Izu A, Boyce W, Bhikha S, Ikulinda BT, Jose L, Koen A, Nana AJ, Moultrie A, Roalfe L, Hunt A, Goldblatt D, Cutland CL, Dorfman JR. Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial. Lancet Infect Dis 2020;20:1426-36. [PMID: 32857992 DOI: 10.1016/S1473-3099(20)30289-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother 2021;:1-10. [PMID: 34726580 DOI: 10.1080/21645515.2021.1985353] [Reference Citation Analysis]
7 Kabir A, Newall AT, Randall D, Menzies R, Sheridan S, Jayasinghe S, Fathima P, Liu B, Moore H, McIntyre P, Gidding HF. Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage. Vaccine 2021;39:1727-35. [PMID: 33622589 DOI: 10.1016/j.vaccine.2021.02.015] [Reference Citation Analysis]
8 Izurieta P, Nieto Guevara J. Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Hum Vaccin Immunother 2021;:1-8. [PMID: 33605846 DOI: 10.1080/21645515.2021.1872341] [Reference Citation Analysis]
9 Fathima P, Gidding HF, McIntyre PB, Snelling TL, McCallum L, de Klerk N, Blyth CC, Liu B, Moore HC. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study. Lancet Child Adolesc Health 2019;3:713-24. [PMID: 31439496 DOI: 10.1016/S2352-4642(19)30249-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
10 Du QQ, Zeng HL, Yuan L, Tang P, Gao W, Xu JJ, Shi W, Leng T, Hu KX, Yao KH. One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people. Vaccine 2021;39:3304-9. [PMID: 33980399 DOI: 10.1016/j.vaccine.2021.02.053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Meder KN, Jayasinghe S, Beard F, Dey A, Kirk M, Cook H, Strachan J, Sintchenko V, Smith H, Giele C, Howden B, Krause V, Mcintyre P. Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians. Clin Infect Dis 2020;70:2607-15. [PMID: 31388670 DOI: 10.1093/cid/ciz731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Rinta-kokko H, Auranen K, Toropainen M, Nuorti JP, Nohynek H, Siira L, Palmu AA. Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland. Vaccine 2020;38:1559-64. [DOI: 10.1016/j.vaccine.2019.11.049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jayasinghe S, Liu B, Gidding H, Gibson A, Chiu C, McIntyre P. Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort. Pediatr Infect Dis J 2019;38:967-73. [PMID: 31408056 DOI: 10.1097/INF.0000000000002407] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Duszynski KM, Stark JH, Cohet C, Huang WT, Shin JY, Lai EC, Man KKC, Choi NK, Khromava A, Kimura T, Huang K, Watcharathanakij S, Kochhar S, Chen RT, Pratt NL. Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety. Pharmacoepidemiol Drug Saf 2021;30:843-57. [PMID: 33634545 DOI: 10.1002/pds.5214] [Reference Citation Analysis]